Predicting the Impact of Polypill Use in a Metabolic Syndrome Population: An Effectiveness and Cost-Effectiveness Analysis

被引：0
|
作者：
Ella Zomer
Alice Owen
Dianna J. Magliano
Zanfina Ademi
Christopher M. Reid
Danny Liew
机构：
[1] Monash University,Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine
[2] Baker IDI Heart and Diabetes Institute,Melbourne EpiCentre
[3] The University of Melbourne,undefined
来源：
American Journal of Cardiovascular Drugs | 2013年 / 13卷
关键词：
Aspirin; Statin; Simvastatin; Relative Risk Reduction; Probabilistic Sensitivity Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：121 / 128
页数：7
相关论文
共 50 条
  • [1] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    BMJ OPEN, 2011, 1 (02):
  • [2] Exploring Uncertainty in Cost-Effectiveness Analysis
    Karl Claxton
    PharmacoEconomics, 2008, 26 : 781 - 798
  • [3] Cost-Effectiveness Analysis of Qsymia for Weight Loss
    Eric A. Finkelstein
    Eliza Kruger
    Sunil Karnawat
    PharmacoEconomics, 2015, 33 : 699 - 706
  • [4] Cost-effectiveness analysis: A tool in the hands of the clinician
    De Carlo, Marco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (08) : 855 - 857
  • [5] Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
    Lyth, Johan
    Svennberg, Emma
    Bernfort, Lars
    Aronsson, Mattias
    Frykman, Viveka
    Al-Khalili, Faris
    Friberg, Leif
    Rosenqvist, Marten
    Engdahl, Johan
    Levin, Lars-Ake
    EUROPEAN HEART JOURNAL, 2023, 44 (03) : 196 - +
  • [6] A Non-inferiority Framework for Cost-Effectiveness Analysis
    Xie, Xuanqian
    Falk, Lindsey
    Brophy, James M.
    Tu, Hong Anh
    Guo, Jennifer
    Gajic-Veljanoski, Olga
    Sikich, Nancy
    Dhalla, Irfan A.
    Ng, Vivian
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) : 291 - 297
  • [7] Cost-Effectiveness Analysis of Cardiovascular Disease Treatment in Japan
    Kodera, Satoshi
    Kiyosue, Arihiro
    Ando, Jiro
    Akazawa, Hiroshi
    Morita, Hiroyuki
    Watanabe, Masafumi
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2017, 58 (06) : 847 - 852
  • [8] Cost-Effectiveness Analysis in Markets with High Fixed Costs
    David M. Cutler
    Keith M. Marzilli Ericson
    PharmacoEconomics, 2010, 28 : 867 - 875
  • [9] Cost-effectiveness of a hypertension management programme in an elderly population: A Markov model
    Perman G.
    Rossi E.
    Waisman G.D.
    Agüero C.
    González C.D.
    Pallordet C.L.
    Figar S.
    Gonzlez Bernaldo de Quirós F.
    Canning J.
    Soriano E.R.
    Cost Effectiveness and Resource Allocation, 9 (1)
  • [10] Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis
    Joshua Schulman-Marcus
    Dorairaj Prabhakaran
    Thomas A Gaziano
    BMC Cardiovascular Disorders, 10
12345